project id: TCGA-SARC; case submitter id: TCGA-K1-A6RT; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; age at index: 48; days to birth: -17739; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 17739; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 528.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of lower limb and hip; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 205; initial weight: 250.0; sample id: 8fc84ae3-c1f9-4382-8e6d-64cfadf72754; sample submitter id: TCGA-K1-A6RT-01A; portion id: de8ff5b5-fad0-4ca8-b802-4b6504e91b85; portion submitter id: TCGA-K1-A6RT-01A-32; slide id: 45ca2746-c50e-4699-bd5b-955abe68fb5e; slide submitter id: TCGA-K1-A6RT-01A-03-TSC; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; section location: TOP;